These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33916489)

  • 1. The COVID-19 Vaccines: Recent Development, Challenges and Prospects.
    Yan Y; Pang Y; Lyu Z; Wang R; Wu X; You C; Zhao H; Manickam S; Lester E; Wu T; Pang CH
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33916489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.
    Begum J; Mir NA; Dev K; Buyamayum B; Wani MY; Raza M
    Transbound Emerg Dis; 2021 May; 68(3):1111-1124. PubMed ID: 32815655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges.
    Kandimalla R; Chakraborty P; Vallamkondu J; Chaudhary A; Samanta S; Reddy PH; De Feo V; Dewanjee S
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.
    Aileni M; Rohela GK; Jogam P; Soujanya S; Zhang B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world.
    Chavda VP; Yao Q; Vora LK; Apostolopoulos V; Patel CA; Bezbaruah R; Patel AB; Chen ZS
    Front Immunol; 2022; 13():961198. PubMed ID: 36263030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants?
    Noor R
    Curr Clin Microbiol Rep; 2021; 8(3):186-193. PubMed ID: 34249605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19.
    Kushwaha ND; Mohan J; Kushwaha B; Ghazi T; Nwabuife JC; Koorbanally N; Chuturgoon AA
    Eur J Med Chem; 2023 Nov; 260():115719. PubMed ID: 37597435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
    Li Q; Wang J; Tang Y; Lu H
    Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
    Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
    Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects.
    Wang S; Li L; Yan F; Gao Y; Yang S; Xia X
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.
    Noor R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combating the Progression of Novel Coronavirus SARS-CoV-2 Infectious Disease: Current State and Future Prospects in Molecular Diagnostics and Drug Discovery.
    Kumar A; Sharma A; Tirpude NV; Thakur S; Kumar S
    Curr Mol Med; 2023; 23(2):127-146. PubMed ID: 34344288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.
    Dash P; Mohapatra S; Ghosh S; Nayak B
    Front Pharmacol; 2020; 11():590154. PubMed ID: 33815095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease.
    Belete TM
    Infect Drug Resist; 2021; 14():151-161. PubMed ID: 33500636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles and Challenges in anti-COVID-19 Vaccine Development.
    Strizova Z; Smetanova J; Bartunkova J; Milota T
    Int Arch Allergy Immunol; 2021; 182(4):339-349. PubMed ID: 33524979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.